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Diabetes is emerging as one of the most significant diseases to threaten 
human health in modern times.  Type 2 diabetes mellitus is predicted to affect 
more than 300 million people by 2025, and currently, 1 in 10 children 
worldwide are obese or grossly overweight.  The huge increase in the 
numbers of individuals affected by type 2 diabetes is associated with poor 
diet, high calorie food intake and a collapse in physical activity in many 
populations throughout the world. The concept of the ‘thrifty gene’ hypothesis 
has emerged to explain this phenomenon.1 Simply stated, humans have 
evolved to be able to cope with the alternating periods of starvation and plenty 
that regularly confronted out ancestors. We therefore have evolved to rapidly 
and efficiently store energy in the form of lipid in adipose tissue to enable us 
to survive periods of famine. Clearly, until modern times, this conferred an 
evolutionary advantage. However, in the modern era of widely available and 
abundant food, this genetic make up is no longer advantageous, but instead 
results in obesity and predisposes us to diseases such as type 2 diabetes.  
The term ‘malnourished’ used to refer exclusively to people who had 
inadequate food intake, but now can equally well be applied to individuals who 
have excessive and inappropriate food intake. 
 
Dentists have long been aware of the importance of a diagnosis of diabetes in 
their patients. Various oral conditions are associated with diabetes, including 
dry mouth, candidal infections, delayed wound healing and periodontal 
disease.  Periodontitis was described as the 6th complication of diabetes in 
1993, along with retinopathy, nephropathy, neuropathy, macrovascular 
disease and altered wound healing.2 However, the links between periodontal 
disease and diabetes were not so well recognised by the medical community 
until rather more recently. Thus, in 2003, the American Diabetes Association 
stated that ‘hypertension, abnormalities of lipid metabolism, and periodontal 
disease are often found in people with diabetes’.3    
 
Much of the prevalence data linking periodontal disease and diabetes was 
gathered in studies of the Pima Indians. This population of native Americans 
in Arizona has an unusually high prevalence of diabetes. The reason for this 
may be linked to the thrifty gene hypothesis.1 The rivers that this population 
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depended upon for crop irrigation were diverted by European settlers to the 
region, leading to crop failure and widespread starvation among the Pima 
Indians. Those who survived would be more likely to possess the thrifty 
genotype, leading to the enrichment of this genotype in the modern day Pima 
population. In present times of plenty, this has resulted in a hugely increased 
prevalence of type 2 diabetes in this population with more than half the 
individuals affected.   
 
Early studies of diabetes and periodontal disease in the Pima Indian 
population identified a greatly increased prevalence and incidence of 
periodontal disease in those individuals who also had type 2 diabetes 
compared to those who did not.4, 5  This was evident in all age groups, and it 
was concluded that those individuals with type 2 diabetes were approximately 
3 times more likely to also have periodontal disease.6  Similar findings of 
increased prevalence of periodontal disease have also been reported in 
European populations with type 2 diabetes.7  In the NHANES III survey in the 
USA, it was reported that adults with poorly controlled diabetes had an almost 
threefold increased risk of having periodontitis compared with adults without 
periodontitis.  Furthermore, adults with diabetes under good glycaemic control 
had no significant increase in risk for periodontal disease.8   
 
Looking at the problem from the other perspective, it has also been reported 
that diabetics with severe periodontal disease are six times more likely to 
have poor glycemic control.9  Further, patients with severe periodontal 
disease have a significantly increased risk for microalbuminaemia and end 
stage renal disease compared to those who do not.10  It has also been 
reported that Pima Indians with severe periodontal disease have an increased 
risk of death from diabetic nephropathy or ischaemic heart disease.11 
 
Patients with type 1 diabetes, including children, have also been reported to 
have increased prevalence of periodontal disease. Thus, in a study of 350 
children with diabetes aged 6-18 years old compared to 350 controls without 
diabetes, it was observed that >20% of periodontal sites in the children with 
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diabetes demonstrated attachment loss >2 mm compared to 8% of sites in the 
non-diabetic controls.12 
 
Taken collectively, the epidemiological studies confirm that diabetes is a 
significant risk factor for periodontal disease, and also that the risk for 
diabetes is greater if diabetes control is poor. People with well controlled 
diabetes do not appear to be at any significantly greater risk for periodontal 
disease than non-diabetics. 
 
The mechanisms that link these two diseases have yet to be fully understood. 
The importance of the host response in periodontal pathogenesis has now 
become firmly established.13  Thus, the challenge presented by the 
subgingival microflora results in a chronic immune-inflammatory response in 
the periodontal tissues. This is characterised by the local production of 
inflammatory mediators including cytokines (such as interleukins), prostanoids 
(such as prostaglandins) and destructive enzymes (such as matrix 
metalloproteinases, including collagenase).  The excessive or dysregulated 
production of these mediators leads to the clinical signs of disease, 
characterised by attachment loss, alveolar bone destruction and pocket 
formation. The concept of the ‘periodontal hyper-responder’ is now 
established which holds that some individuals mount an aggressive or 
excessive inflammatory response to a given plaque challenge, leading to 
more rapid periodontal tissue breakdown and the signs of periodontal 
disease. This hypothesis may explain why some patients are more 
susceptible to periodontal disease, including aggressive forms of periodontitis. 
 
The inflammatory response in the periodontal tissues in response to the 
plaque challenge is complex and involves networks of cytokines functioning in 
synergy. It is likely that alterations in immunologically active molecules as a 
result of diabetes may alter cytokine networks in the periodontium, and this is 
the scientific basis for the increased susceptibility to periodontal disease seen 
in people with diabetes.  That is, diabetes modifies inflammatory processes 
resulting in further dysregulation of immune-inflammatory responses, resulting 
in increased periodontal destruction. This hypothesis is supported by 
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emerging concepts of diabetes itself as an inflammatory condition.  Thus, a 
low grade systemic inflammation precedes a diagnosis of type 2 diabetes.14 
Further, plasma interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α) 
levels are elevated in the plasma of obese patients and those with type 2 
diabetes.15 Hyperglycaemia also results in increased levels of IL-6, IL-12 and 
TNF-α. 
 
One important source of cytokines in diabetes is the adipose tissue.  
Previously, adipose tissue was considered to be a rather passive repository 
for the storage of lipid. However, it is now recognised that it is an active 
endocrine organ that secretes hormones that regulate appetite and 
metabolism. Adipose tissue also secretes cytokines such as TNF-α and IL-6. 
These have direct pro-inflammatory effects on inflammatory cells, including 
those in the periodontal tissues. The adipose tissue also secretes adipokines, 
such as leptin and adiponectin.  Leptin is an important stimulator of 
inflammatory responses. It stimulates neutrophil chemotaxis and stimulates 
cytokine release by monocytes.16 The levels of leptin correlate with the mass 
of adipose tissue, and are elevated in obese individuals.17  High leptin levels 
have also been associated with an increased risk of developing type 2 
diabetes.18 It is therefore certainly plausible that elevated leptin levels in 
patients with diabetes may contribute to enhanced periodontal tissue 
destruction by activation of pro-inflammatory responses in the periodontium. A 
further adipokine that may be relevant in the context of periodontitis is 
adiponectin. Adiponectin is generally considered to have anti-inflammatory 
effects, and low levels of adiponectin have been associated with obesity, 
diabetes and cardiovascular disease.19 
 
Another mechanism that may link diabetes and periodontal disease is that of 
impaired neutrophil function.  Impaired chemotaxis, adherence and neutrophil 
function have been reported in patients with diabetes. Furthermore, delayed 
apoptosis (programmed cell death) has been reported in patients with 
diabetes.20  Neutrophils are a key component of the defence mechanisms 
against periodontal plaque bacteria in periodontal disease. However, if 
apoptosis is delayed, this will lead to increased retention of neutrophils in the 
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periodontal tissues which in turn could lead to increased tissue damage by the 
release of destructive enzymes such as matrix metalloproteinases and 
reactive oxygen species by the neutrophils. 
 
A further mechanism that links periodontal disease and diabetes is the 
formation of advanced glycation end-products (AGEs). In conditions of 
hyperglycaemia, glycosylation of structural proteins and matrix molecules 
occurs, resulting in the formation of AGEs.  This process occurs in people 
without diabetes too, but the rate of formation of AGEs is greatly increased in 
people with diabetes.  The formation of AGEs is irreversible, and increased 
cross-linking of collagen molecules by this process contributes to other 
complications of diabetes as a result of decreased elasticity of blood vessels.  
Monocytes possess a receptor for AGEs, known as RAGE (the receptor for 
AGE). Binding of RAGE on monocytes to AGEs results in the release of pro-
inflammatory mediators by the monocytes, such as IL-1β, TNF-α and IL-6,21 
which contribute to further periodontal tissue destruction. AGEs also enhance 
the respiratory burst in neutrophils,22 again resulting in increased tissue 
damage. AGE formation contributes to many of the classic complications of 
diabetes, particularly those associated with reduced elasticity of blood 
vessels, and also is very likely to contribute to enhanced tissue destruction in 
periodontitis. 
 
Thus, there are many mechanisms that link periodontal disease and diabetes. 
Deposition of AGEs and subsequent activation of monocytes via RAGE and 
altered neutrophil function enhance inflammatory responses.  Adipose tissue 
is responsible for the secretion of pro-inflammatory cytokines and adipokines 
which further enhance inflammatory responses.  In inflamed periodontal 
tissues, the upregulation of inflammatory responses and dysregulation of 
cytokine networks is likely to result in enhanced tissue breakdown, leading to 
the signs of disease and the observed increased susceptibility to periodontitis 
that is seen in patients with diabetes. What is particularly exciting is to identify 
whether treating periodontal disease may have a beneficial impact on 
diabetes control. This issue was addressed in a meta-analysis of 10 
intervention studies in which patients with diabetes and periodontal disease 
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received periodontal treatment.23 Following treatment, there was a very small 
improvement in glycaemic control as measured by glycated haemoglobin 
levels (HbA1c), with an absolute reduction of HbA1c of 0.66% in patients with 
type 2 diabetes.  The small number of studies to date and their varied design 
limits the ability to reach firm conclusions on this issue, but they give promise 
that periodontal therapy may have a positive impact on glycaemic control. 
 
Taken together, we can firmly conclude that diabetes increases the risk for 
periodontal disease compared to non-diabetics. This increased susceptibility 
most likely results from pathological processes that are common to both 
diseases and/or upregulated in the context of diabetes. There is also evidence 
that periodontal treatment may improve glycaemic control, and this will 
become clearer as more research is conducted. 
 
The implications for the dental team are quite clear. We need to be alert for a 
diagnosis of periodontal disease in people with diabetes, even in young 
children. Changing demographics and the huge increases in the numbers of 
people affected by diabetes may contribute to an increased prevalence of 
periodontal disease in the future. Individuals from emerging economies are 
particularly vulnerable to this when they adopt a more Western form of 
lifestyle characterised by excessive intake of high calorie foods and a 
reduction in physical exercise.  As dentists, we need to liaise with our medical 
colleagues regarding the management of patients with diabetes and become 
more involved in their medical care. It is important to always ask patients with 
diabetes about their level of glycaemic control, including what their most 
recent HbA1c values are.  If the patient does not know, this can provide good 
evidence of their likely level of control and/or compliance!   
 
Prevention of periodontal diseases is fundamentally important in patients with 
diabetes because of the potential negative impact of untreated periodontitis 
on glycaemic control and diabetic complications. Improved awareness of the 
dental team and better joint working with our medical colleagues is important 
to improve the periodontal and medical management of people with diabetes.  
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Ideally, patients with diabetes would be routinely referred for periodontal 
screening as part of the long term management of their diabetes. 
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